599 related articles for article (PubMed ID: 31484749)
1. Human Antiviral Protein MxA Forms Novel Metastable Membraneless Cytoplasmic Condensates Exhibiting Rapid Reversible Tonicity-Driven Phase Transitions.
Davis D; Yuan H; Liang FX; Yang YM; Westley J; Petzold C; Dancel-Manning K; Deng Y; Sall J; Sehgal PB
J Virol; 2019 Nov; 93(22):. PubMed ID: 31484749
[TBL] [Abstract][Full Text] [Related]
2. Murine GFP-Mx1 forms nuclear condensates and associates with cytoplasmic intermediate filaments: Novel antiviral activity against VSV.
Sehgal PB; Yuan H; Scott MF; Deng Y; Liang FX; Mackiewicz A
J Biol Chem; 2020 Dec; 295(52):18023-18035. PubMed ID: 33077519
[TBL] [Abstract][Full Text] [Related]
3. Rapid Reversible Osmoregulation of Cytoplasmic Biomolecular Condensates of Human Interferon-α-Induced Antiviral MxA GTPase.
Sehgal PB; Yuan H; Jin Y
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361529
[TBL] [Abstract][Full Text] [Related]
4. Oral Antiviral Defense: Saliva- and Beverage-like Hypotonicity Dynamically Regulate Formation of Membraneless Biomolecular Condensates of Antiviral Human MxA in Oral Epithelial Cells.
Sehgal PB; Yuan H; Centone A; DiSenso-Browne SV
Cells; 2024 Mar; 13(7):. PubMed ID: 38607029
[TBL] [Abstract][Full Text] [Related]
5. Metastable biomolecular condensates of interferon-inducible antiviral Mx-family GTPases: A paradigm shift in the last three years.
Sehgal PB
J Biosci; 2021; 46(3):. PubMed ID: 34323222
[TBL] [Abstract][Full Text] [Related]
6. Biomolecular condensates in cell biology and virology: Phase-separated membraneless organelles (MLOs).
Sehgal PB; Westley J; Lerea KM; DiSenso-Browne S; Etlinger JD
Anal Biochem; 2020 May; 597():113691. PubMed ID: 32194074
[TBL] [Abstract][Full Text] [Related]
7. [Alpha interferon, antiviral proteins and their value in clinical medicine].
Chieux V; Hober D; Chehadeh W; Wattré P
Ann Biol Clin (Paris); 1999; 57(6):659-66. PubMed ID: 10572214
[TBL] [Abstract][Full Text] [Related]
8. Interferon-α-induced cytoplasmic MxA structures in hepatoma Huh7 and primary endothelial cells.
Davis D; Yuan H; Yang YM; Liang FX; Sehgal PB
Contemp Oncol (Pozn); 2018; 22(2):86-94. PubMed ID: 30150884
[TBL] [Abstract][Full Text] [Related]
9. Biomolecular condensates in cancer cell biology: interleukin-6-induced cytoplasmic and nuclear STAT3/PY-STAT3 condensates in hepatoma cells.
Sehgal PB
Contemp Oncol (Pozn); 2019; 23(1):16-22. PubMed ID: 31061632
[TBL] [Abstract][Full Text] [Related]
10. MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.
Maarifi G; Hannoun Z; Geoffroy MC; El Asmi F; Zarrouk K; Nisole S; Blondel D; Chelbi-Alix MK
J Virol; 2016 Jul; 90(14):6598-6610. PubMed ID: 27170750
[TBL] [Abstract][Full Text] [Related]
11. Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity.
Dick A; Graf L; Olal D; von der Malsburg A; Gao S; Kochs G; Daumke O
J Biol Chem; 2015 May; 290(20):12779-92. PubMed ID: 25829498
[TBL] [Abstract][Full Text] [Related]
12. Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity.
Ponten A; Sick C; Weeber M; Haller O; Kochs G
J Virol; 1997 Apr; 71(4):2591-9. PubMed ID: 9060610
[TBL] [Abstract][Full Text] [Related]
13. Correlation between the anti-virus-induced cytopathic effect activity of interferon-alpha subtypes and induction of MxA protein in vitro.
Schanen C; Chieux V; Lobert PE; Harvey J; Hober D
Microbiol Immunol; 2006; 50(1):19-24. PubMed ID: 16428869
[TBL] [Abstract][Full Text] [Related]
14. Interferon-induced Mx proteins in antiviral host defense.
Haller O; Staeheli P; Kochs G
Biochimie; 2007; 89(6-7):812-8. PubMed ID: 17570575
[TBL] [Abstract][Full Text] [Related]
15. Vesicular stomatitis virus transcription inhibited by purified MxA protein.
Schwemmle M; Weining KC; Richter MF; Schumacher B; Staeheli P
Virology; 1995 Jan; 206(1):545-54. PubMed ID: 7831809
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA Lnc-MxA Inhibits Beta Interferon Transcription by Forming RNA-DNA Triplexes at Its Promoter.
Li X; Guo G; Lu M; Chai W; Li Y; Tong X; Li J; Jia X; Liu W; Qi D; Ye X
J Virol; 2019 Nov; 93(21):. PubMed ID: 31434735
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein.
Staeheli P; Pavlovic J
J Virol; 1991 Aug; 65(8):4498-501. PubMed ID: 1649344
[TBL] [Abstract][Full Text] [Related]
18. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein.
Pavlovic J; Zürcher T; Haller O; Staeheli P
J Virol; 1990 Jul; 64(7):3370-5. PubMed ID: 2161946
[TBL] [Abstract][Full Text] [Related]
19. Subcellular Localization of MxB Determines Its Antiviral Potential against Influenza A Virus.
Steiner F; Pavlovic J
J Virol; 2020 Oct; 94(22):. PubMed ID: 32907985
[TBL] [Abstract][Full Text] [Related]
20. Oligomerization and GTP-binding Requirements of MxA for Viral Target Recognition and Antiviral Activity against Influenza A Virus.
Nigg PE; Pavlovic J
J Biol Chem; 2015 Dec; 290(50):29893-906. PubMed ID: 26507657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
